Clemons M - Search Results

1

Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer--an inspection of the evidence base informing clinical decision-making.

Hutton B, Clemons M, Mazzarello S, Kuchuk I, Skidmore B, Ng T. Hutton B, et al. Among authors: clemons m. Cancer Treat Rev. 2015 Dec;41(10):951-9. doi: 10.1016/j.ctrv.2015.09.007. Epub 2015 Sep 30. Cancer Treat Rev. 2015. PMID: 26442474 Review.

2

The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone.

Clemons M, Gharif R, Howell A. Clemons M, et al. Cancer Treat Rev. 1998 Jun;24(3):173-84. doi: 10.1016/s0305-7372(98)90048-2. Cancer Treat Rev. 1998. PMID: 9767733 Review. No abstract available.

3

Breast cancer risk following irradiation for Hodgkin's disease.

Clemons M, Loijens L, Goss P. Clemons M, et al. Cancer Treat Rev. 2000 Aug;26(4):291-302. doi: 10.1053/ctrv.2000.0174. Cancer Treat Rev. 2000. PMID: 10913384 Review.

4

Does treatment at the time of locoregional failure of breast cancer alter prognosis?

Clemons M, Hamilton T, Goss P. Clemons M, et al. Cancer Treat Rev. 2001 Apr;27(2):83-97. doi: 10.1053/ctrv.2001.0205. Cancer Treat Rev. 2001. PMID: 11319847 Review.

5

Tamoxifen ("Nolvadex"): a review.

Clemons M, Danson S, Howell A. Clemons M, et al. Cancer Treat Rev. 2002 Aug;28(4):165-80. doi: 10.1016/s0305-7372(02)00036-1. Cancer Treat Rev. 2002. PMID: 12363457 Review.

6

Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?

Clemons M, Coleman RE, Verma S. Clemons M, et al. Cancer Treat Rev. 2004 Jun;30(4):325-32. doi: 10.1016/j.ctrv.2004.03.004. Cancer Treat Rev. 2004. PMID: 15145507 Review.

7

Should oral bisphosphonates be standard of care in women with early breast cancer?

Clemons M, Verma S. Clemons M, et al. Breast Cancer Res Treat. 2005 Apr;90(3):315-8. doi: 10.1007/s10549-004-4259-3. Breast Cancer Res Treat. 2005. PMID: 15830146 Review.

8

Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review.

Trudeau M, Sinclair SE, Clemons M; Breast Cancer Disease Site Group. Trudeau M, et al. Among authors: clemons m. Cancer Treat Rev. 2005 Jun;31(4):283-302. doi: 10.1016/j.ctrv.2005.03.007. Cancer Treat Rev. 2005. PMID: 15916855 Review.

9

Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence.

Dent R, Clemons M. Dent R, et al. Among authors: clemons m. Cancer Treat Rev. 2006 Apr;32(2):144-8. doi: 10.1016/j.ctrv.2006.01.005. Epub 2006 Mar 6. Cancer Treat Rev. 2006. PMID: 16517084 Clinical Trial. No abstract available.

10

Identifying menopause in breast cancer patients: considerations and implications.

Clemons M, Simmons C. Clemons M, et al. Breast Cancer Res Treat. 2007 Aug;104(2):115-20. doi: 10.1007/s10549-006-9401-y. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061039 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters